$0.39
+
$0.06 (18.18%)
End-of-day quote: 11/30/2022
NasdaqGM:AGTC
Beacon Therapeutics (USA) Annual Report
| Year | Year | |||
|---|---|---|---|---|
| Rev. | Revenue |
|
||
| GM % | Gross Margin % |
|
||
| OM | Operating Margin |
|
||
| EPS | Earnings Per Share |
|
$0.00 | $0.00 |
| Div. | Dividends |
|
||
| PR % | Payout Ratio % |
|
||
| Sha. | Shares |
|
||
| OCF | Operating Cash Flow |
|
||
| FCF | Free Cash Flow |
|
||
| FCFS | Free Cash Flow Per Share |
|
